Polypeptide-Based Copper Ionophore for In Situ Glutathione-Triggered Chemodynamic and Chemotherapy.
Copper-based nanomedicine
GSH depletion
Polymeric ionophore
Polypeptides
Stimulus responsive
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
01 Oct 2024
01 Oct 2024
Historique:
medline:
1
10
2024
pubmed:
1
10
2024
entrez:
1
10
2024
Statut:
aheadofprint
Résumé
Intracellular copper ion homeostasis has become an attractive target for cancer therapy. Herein, we report a 2,2'-dipicolylamine (DPA) functionalized polyglutamate derivative (PDHB) which is capable of rapidly forming PDHB-copper complex (PDHB@Cu) due to the strong coordination ability of pendant DPA with Cu
Identifiants
pubmed: 39351992
doi: 10.1021/acs.molpharmaceut.4c00883
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM